Dapoxetine Impurity 34 CAS 1083-30-3

Description

Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Dapoxetine Impurity 34.

CATO supplies Dapoxetine Impurity 34 (CAS 1083-30-3), a pharmacopoeial impurity reference standard (molecular formula C15H14O, MW 210.27 g/mol) used for the identification and quantification of trace impurities in APIs.

Owing to a hydroxyl group, an ether linkage, a polycyclic aromatic system, Dapoxetine Impurity 34 is typically pale yellow to yellow low-melting solid. Its solid-state physicochemical attributes — including a molecular weight of 210.27 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).

Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.

CATO manufactures Dapoxetine Impurity 34 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com